← Scroll for more →
Financial Statements — ALVO
Balance Sheet
(in billions USD)| Metric | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q4 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 0.17 | 0.15 | 0.05 | 0.01 | 0.01 | 0.07 | 0.02 |
| Inventory | 0.22 | 0.16 | 0.13 | 0.10 | 0.07 | 0.07 | -- |
| Total Current Assets | 0.57 | 0.51 | 0.46 | 0.29 | 0.19 | 0.23 | -- |
| Goodwill | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | -- |
| Total Non-current Assets | 0.91 | 0.88 | 0.77 | 0.78 | 0.76 | 0.60 | -- |
| Total Assets | 1.49 | 1.39 | 1.22 | 1.07 | 0.95 | 0.83 | -- |
| Total Current Liabilities | 0.30 | 0.28 | 0.19 | 1.20 | 0.26 | 0.17 | -- |
| Total Non-current Liabilities | 1.47 | 1.29 | 1.44 | 0.47 | 1.62 | 1.23 | -- |
| Total Liabilities | 1.77 | 1.57 | 1.63 | 1.67 | 1.88 | 1.39 | -- |
| Retained Earnings | (2.41) | (2.30) | (2.44) | (2.36) | (2.21) | (1.65) | -- |
| Total Stockholder Equity | (0.28) | (0.17) | (0.41) | (0.61) | (0.93) | (0.56) | (0.14) |
← Scroll for more columns →
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2025 | Q2 2024 |
|---|---|---|
| Total Revenue | 306.00 | 235.59 |
| Research & Development | 92.89 | 97.48 |
| Selling, General & Admin | 45.35 | 29.55 |
| Operating Income | 28.64 | 43.45 |
| Pretax Income | 102.73 | (148.37) |
| Tax Provision | (38.99) | 5.13 |
| Net Income | 141.72 | (153.50) |
| Basic EPS | 0.50 | (0.61) |
| Diluted EPS | 0.49 | (0.61) |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2025 | Q2 2024 |
|---|---|---|
| Operating Cash Flow | 68.29 | (126.00) |
| Investing Cash Flow | (49.00) | (10.57) |
| Financing Cash Flow | 77.31 | 137.18 |
← Scroll for more columns →